Precigen
PGEN
#5241
Rank
โ‚น159.28 B
Marketcap
โ‚น444.24
Share price
5.82%
Change (1 day)
25.27%
Change (1 year)

Earnings for Precigen (PGEN)

Earnings in 2026 (TTM): -โ‚น13.95 Billion

According to Precigen's latest financial reports the company's current earnings are โ‚น85.71 Million. In 2025 the company made an earning of -โ‚น23.55 Billion a decrease over its 2024 earnings that were of -โ‚น12.03 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Precigen from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น13.95 Billion-40.75%
2025 -โ‚น23.55 Billion95.77%
2024 -โ‚น12.03 Billion32.86%
2023 -โ‚น9.06 Billion20.5%
2022 -โ‚น7.52 Billion-23.33%
2021 -โ‚น9.8 Billion60.11%
2020 -โ‚น6.12 Billion-65.1%
2019 -โ‚น17.54 Billion-65.19%
2018 -โ‚น50.37 Billion313.44%
2017 -โ‚น12.19 Billion-33.2%
2016 -โ‚น18.24 Billion123.22%
2015 -โ‚น8.17 Billion1.47%
2014 -โ‚น8.06 Billion109.54%
2013 -โ‚น3.85 Billion-50.04%
2012 -โ‚น7.69 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Organovo
ONVO
-โ‚น0.24 Billion-98.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
-โ‚น6.87 Billion-53.67%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
-โ‚น20.99 Billion 41.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
-โ‚น11.26 Billion-24.03% Jersey